Concepedia

M. E. Cooper

ME

10

Publications

2.4K

Citations

10

H-Index

1988

Active since

Affiliations

The University of Melbourne(Current)

Heidelberg Repatriation Hospital

Baker Heart and Diabetes Institute

Austin Hospital

M. E. Cooper is an author at The University of Melbourne specializing in medicine, diabetes, and hypertension.

Top concepts

Publications per year

1988–2013

10

Publications

10

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

C. E. Mogensen, Steen Neldam, I. Tikkanen et al. · BMJ · 2000 · 1K citations · Full text

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

B. M. Brenner, M. E. Cooper, Dick de Zeeuw · ACC Current Journal Review · 2002 · 511 citations · Full text

, , +13

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

M. E. Cooper, Geoffrey Boner, Zemin Cao et al. · Diabetologia · 2001 · 246 citations · Full text

, , +8

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

Richard E. Gilbert, Angela Cox, Linlin Wu et al. · Diabetes · 1998 · 203 citations

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation

M. E. Cooper, Vicki Thallas, Josephine M. Forbes et al. · Diabetologia · 2000 · 103 citations · Full text

, , +6

Rows per page

1–5 of 10